RxDoctor Payments Data

Melanie Makhija

Allergy & Immunology · Chicago, ILNPI 1790094423

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $48,606 of the $55,727 with a category attached, or 87.2%. Aimmune Therapeutics, Inc. accounts for 82.1% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $45,020 and has fallen 91.9% since, to $3,625 in 2023.

$55,727in general payments, 2019–2025

Across 48 payments — averaging $1160.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aimmune Therapeutics, Inc.$46K
  • Grifols USA, LLC$7K
  • Regeneron$3K
  • Genentech, Inc.$36
  • AstraZeneca$17
$345,813in research payments, 2019–2025

Across 73 payments — averaging $4737.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$232K
  • Aimmune Therapeutics, Inc.$112K
  • Novartis$2K

What the payments were for

  • Consulting fees$3,2306%
  • Speaking & faculty fees$48,60687%
  • Travel & lodging$3,4016%
  • Food & beverage$4891%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$55,727 in reported general payments places this provider in the 85th percentile of 161 allergy & immunology providers in Illinois.

See all allergy & immunology providers in Illinois

Other allergy & immunology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →